Ibandronate

Known as: (1-hydroxy-3-(methylpentylamino)propylidene)bisphosphonate, 1-hydroxy-3-(methylpentylamino)propylidenebisphosphonate 
A synthetic nitrogen-containing bisphosphonate. Ibandronate inhibits farnesyl pyrophosphate synthase, resulting in a reduction in geranylgeranyl… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
PURPOSE The aromatase inhibitor anastrozole is a highly effective well-tolerated treatment for postmenopausal endocrine… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Review
2007
Review
2007
Bisphosphonates (BPs) are well established as the leading drugs for the treatment of osteoporosis. There is new knowledge about… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND Reducing bisphosphonate dosing frequency may improve suboptimal adherence to treatment and therefore therapeutic… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2006
Highly Cited
2006
OBJECTIVE Although oral bisphosphonates are effective treatments for postmenopausal women with osteoporosis, oral dosing may be… (More)
  • figure 1
  • table 1
  • figure 3
  • figure 2
  • table 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
UNLABELLED Oral daily (2.5 mg) and intermittent ibandronate (between-dose interval of >2 months), delivering a similar cumulative… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
The objective of this study is to assess the effect of oral ibandronate on bone pain and quality of life in women with metastatic… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND This phase III study compared the efficacy of the new potent bisphosphonate, ibandronate, with placebo as intravenous… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2001
Highly Cited
2001
The present experiments were carried out to test the hypothesis that artery calcification is linked to bone resorption by… (More)
  • figure 1
  • table 1
  • figure 4
  • figure 3
  • table I
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Bisphosphonate (BP), a specific inhibitor of osteoclasts, has been widely used as a beneficial agent for the treatment of bone… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Multiple steps are involved in the metastasis of cancer cells from primary sites to distant organs. These steps should be… (More)
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?